Broad-based growth in radiopharmaceuticals and contrast products propelled Covidien's Imaging Solutions business unit to an 18% increase in sales in its fiscal third quarter.
For the period (end-June 30), the division of the Hamilton, Bermuda-based firm had sales of $319 million, up from $271 million in the fiscal third quarter of last year. Covidien does not provide specific earnings figures for each business unit.
In quarterly highlights, both radiopharmaceuticals and contrast products grew at a strong double-digit pace, according to Covidien. Growth in radiopharmaceuticals was paced by good performance in the U.S., while higher contrast product volumes in Europe, Asia, and Latin America more than offset pricing pressure in the U.S., Covidien said.
Related Reading
Covidien posts strong Q2, May 7, 2008
Covidien gets tentative nod for generic sestamibi, February 27, 2008
Covidien settles Medrad litigation, February 14, 2008
NRC investigates Covidien production issue, February 8, 2008
Medical sales drive Covidien's Q1 growth, February 7, 2008
Copyright © 2008 AuntMinnie.com
![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
